Search This Blog

Wednesday, August 28, 2019

Premarket analyst action, Aug. 28

VistaGen Therapeutics (OTC:VTGN) initiated with Outperform rating and $7 (+999% upside) price target at William Blair. Shares up 8% premarket.
Myovant Sciences (NYSE:MYOV) resumed with Buy rating and $20 (154% upside) price target at Goldman Sachs.
Pfizer (NYSE:PFE) upgraded to Hold with a $36 (5% upside) price target at DZ Bank. Shares up 1% premarket.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)